About Antiven
Antiven is a company based in United Kingdom founded in 2023. It operates as a B2B. Antiven offers products and services including Lyophilised Vaccine. Antiven operates in a competitive market with competitors including Biological E, Altimmune, Vaxart, Allergy Therapeutics and Medicago, among others.
- Headquarter United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Antiven Private Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antiven
Antiven offers a comprehensive portfolio of products and services, including Lyophilised Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Thermostable polyvalent vaccine for treating snake bite envenomation in humans and animals.
Funding Insights of Antiven
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Antiven
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Antiven
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Antiven Comparisons
Competitors of Antiven
Antiven operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Altimmune, Vaxart, Allergy Therapeutics and Medicago, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for treating multiple infectious diseases
|
|
| domain | founded_year | HQ Location |
Aluminum-free allergy vaccines and diagnostics are developed for treatment.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines to treat pandemic and seasonal influenza
|
|
| domain | founded_year | HQ Location |
Cancer vaccines using immune redirection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Antiven
When was Antiven founded?
Antiven was founded in 2023.
Where is Antiven located?
Antiven is headquartered in United Kingdom.
What does Antiven do?
Antiven is a vaccine development company that utilizes biotechnology and proteomics to produce thermostable, polyvalent vaccines for snake bite envenomation. It focuses on saving lives, reducing poverty, and improving access to treatments in remote areas, including for livestock. The company conducts patented research and is registered in England, with leadership from experts trained internationally.
Who are the top competitors of Antiven?
Antiven's top competitors include Biological E, Vaxart and Allergy Therapeutics.
What products or services does Antiven offer?
Antiven offers Lyophilised Vaccine.